SCOPUS 정보 검색 플랫폼

Volumn 107, Issue 4, 2012, Pages 585-587

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

(16) Corrie, P G a Bulusu, R b Wilson, C B b Armstrong, G a Bond, S a Hardy, R a Lao Sirieix, S a Parashar, D a,k Ahmad, A c Daniel, F d Hill, M e Wilson, G f Blesing, C g Moody, A M h McAdam, K i Osborne, M j

a ADDENBROOKE S HOSPITAL (United Kingdom)

b BEDFORD HOSPITAL (United Kingdom)

c QUEEN ELIZABETH HOSPITAL (United Kingdom)

d DERRIFORD HOSPITAL (United Kingdom)

e MAIDSTONE HOSPITAL (United Kingdom)

f CHRISTIE HOSPITAL (United Kingdom)

g GREAT WESTERN HOSPITAL (United Kingdom)

h WEST SUFFOLK HOSPITAL (United Kingdom)

i PETERBOROUGH CITY HOSPITAL (United Kingdom)

more..

Author keywords

capecitabine; hand foot syndrome; pyridoxine; randomised trial

Indexed keywords

CAPECITABINE; PLACEBO; PYRIDOXINE;

AGED; ANOREXIA; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE DRUG DOSE; TREATMENT PLANNING; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HAND-FOOT SYNDROME; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PYRIDOXINE;

EID: 84864884481 PISSN: 00070920 EISSN: 15321827 Source Type: Journal
DOI: 10.1038/bjc.2012.318 Document Type: Article

Times cited : (32)

References (8)

1
- 0002794423
- Pyridoxine (B6) and amelioration of hand/foot syndrome
- (abstr 393)
- Beveridge RA, Kales AN, Binder RA, Miller JA, Virts SG (1990) Pyridoxine (B6) and amelioration of hand/foot syndrome. Proc Am Soc Clin Oncol 9: 102a (abstr 393)
- (1990) Proc Am Soc Clin Oncol , vol.9
- Beveridge, R.A.¹ Kales, A.N.² Binder, R.A.³ Miller, J.A.⁴ Virts, S.G.⁵

2
- 77956297628
- Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia
- Chalermchai T, Tantiphlachiva K, Suwanrusme H, Voravud N, Sriuranpong V (2010) Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia. Asia-Pacific J Clin Oncol 6: 155-160
- (2010) Asia-Pacific J Clin Oncol , vol.6 , pp. 155-160
- Chalermchai, T.¹ Tantiphlachiva, K.² Suwanrusme, H.³ Voravud, N.⁴ Sriuranpong, V.⁵

3
- 0025217908
- Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion
- Fabian CJ, Molina R, Slavik M, Dahlberg S, Giri S, Stephens R (1990) Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 8: 57-63
- (1990) Invest New Drugs , vol.8 , pp. 57-63
- Fabian, C.J.¹ Molina, R.² Slavik, M.³ Dahlberg, S.⁴ Giri, S.⁵ Stephens, R.⁶

4
- 33750702575
- Management of hand-foot syndrome induced by capecitabine
- Gressett SM, Stanford BL, Hardwicke F (2006) Management of hand-foot syndrome induced by capecitabine. J Oncol Pharm Pract 12: 131-141
- (2006) J Oncol Pharm Pract , vol.12 , pp. 131-141
- Gressett, S.M.¹ Stanford, B.L.² Hardwicke, F.³

5
- 77956257728
- Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: Results of a randomized, double-blind, placebo-controlled study
- Kang YK, Lee SS, Yoon DH, Lee SY, Chun YJ, Kim MS, Ryu MH, Chang HM, Lee JL, Kim TW (2010) Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study. J Clin Oncol 28: 3824-3829
- (2010) J Clin Oncol , vol.28 , pp. 3824-3829
- Kang, Y.K.¹ Lee, S.S.² Yoon, D.H.³ Lee, S.Y.⁴ Chun, Y.J.⁵ Kim, M.S.⁶ Ryu, M.H.⁷ Chang, H.M.⁸ Lee, J.L.⁹ Kim, T.W.¹⁰

6
- 0024971582
- Pyridoxine for the palmar-plantar erythrodysesthesia syndrome
- Vukelja SJ, Lombardo FA, James WD, Weiss RB (1989) Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 111: 688-689
- (1989) Ann Intern Med , vol.111 , pp. 688-689
- Vukelja, S.J.¹ Lombardo, F.A.² James, W.D.³ Weiss, R.B.⁴

7
- 0026511536
- Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: A study of the Eastern Cooperative Oncology Group
- Wiernik PH, Yeap B, Vogl SE, Kaplan BH, Comis RL, Falkson G, Davis TE, Fazzini E, Cheuvart B, Horton J (1992) Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group. Cancer Invest 10: 1-9
- (1992) Cancer Invest , vol.10 , pp. 1-9
- Wiernik, P.H.¹ Yeap, B.² Vogl, S.E.³ Kaplan, B.H.⁴ Comis, R.L.⁵ Falkson, G.⁶ Davis, T.E.⁷ Fazzini, E.⁸ Cheuvart, B.⁹ Horton, J.¹⁰

8
- 84860442682
- Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: Result of a singlecenter, prospective randomized phase III trial
- Zhang RX, Wu XJ, Wan DS, Lu ZH, Kong LH, Pan ZZ, Chen G (2012) Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a singlecenter, prospective randomized phase III trial. Annals Oncol 23: 1348-1353
- (2012) Annals Oncol , vol.23 , pp. 1348-1353
- Zhang, R.X.¹ Wu, X.J.² Wan, D.S.³ Zh, L.⁴ Kong, L.H.⁵ Pan, Z.Z.⁶ Chen, G.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.